Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis

Journal of Negative Results in BioMedicine

Volumn 5, Issue , 2006, Pages

  Manna, I ^a   Valentino, P ^b   La Russa, A ^a   Condino, F ^a   Nistico R ^b   Liguori, M ^a   Clodomiro, A ^b   Andreoli, V ^a   Pirritano, D ^b   Cittadella, R ^a   Quattrone, A ^a,b  

^a CNR   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ALLELE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PROMOTER REGION; PROTEIN BLOOD LEVEL;

ALLELES; COGNITION DISORDERS; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; MULTIPLE SCLEROSIS; PEROXIDASE; POLYMORPHISM, GENETIC;

EID: 33646372460     PISSN: 14775751     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-5-3     Document Type: Article

References (11)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F: Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41:685-691.
2. Hogancamp WE, Rodriguez M, Weinshenker BG: The epidemiology of Multiple Sclerosis. Mayo Clin Proc 1997, 72:871-878.
3. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G: Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998, 70(5):2212-5.
4. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF: An Alu element in the Myeloperoxidase promoter contains a composite SP1-tyroid hormone-retinoic acid response element. J Biol Chem 1996, 271:14412-14420.
5. Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T, Smith RA, Nelson JR, Reynolds WF: Immunohistochemical and genetic evidence of Myeloperoxidase involvement in Multiple Sclerosis. J Neuroimmunol 1997, 78:97-107.
6. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG: Association of a myeloperoxidase promoter polymorphism with multiple sclerosis. J Neuroimmunol 2000, 105(2):189-94.
7. Nelissen I, Fiten P, Vandenbroeck K, Hillert J, Olsson T, Marrosu MG, Opdenakker G: PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia. Neuroimmunol 2000, 108(1-2):153-9.
8. Zakrzewska-Pniewska B, Styczynska M, Podlecka A, Samocka R, Peplonska B, Barcikowska M, Kwiecinski H: Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis. Mult Scler 2004, 10(3):266-71.
9. Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah E: Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Expe Neurol 1999, 78:97-107.
10. Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, Farina D, Fazio MC, Girlanda P, Le Pira F, Liguori M, Lugaresi A, Nocentini U, Reggio A, Salemi G, Tedeschi G, Trojano M, Valentino P, Quattrone A: Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 2004, 251(10):1208-14.
11. Zappia M, Manna I, Serra P, Cittadella R, Andreoli V, La Russa A, Annesi F, Spadafora P, Romeo N, Nicoletti G, Messina D, Gambardella A, Quattrone A: Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Arch Neurol 2004, 61(3):341-4.